← FDA DRUG APPROVALS

FDA ANDA · ANDA203687

FINASTERIDE

Sponsor: AUROBINDO PHARMA LTD

APPLICATION
ANDA203687
TYPE
ANDA
ORIGINAL APPROVAL
2013-11-05
LATEST ACTION
2023-01-23
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

FINASTERIDEPrescription
FINASTERIDE 1MG · TABLET · ORAL

Approval history

2023-01-23Labeling · Supplement 9 · standardAP
2023-01-23Labeling · Supplement 11 · standardAP
2016-02-25Labeling · Supplement 4 · standardAP
2014-12-14Labeling · Supplement 1 · standardAP
2013-11-05UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →